Chris helped me analyze the term sheet I was handed as a starting point, not a firm offer. The framework for capital markets and regulatory exposure made me realize the problems with the term sheet were structural and not commercial, reducing potential conflict in the negotiation and changing how I approached the discussion.
The people who learned before the stakes were real.
Named CEOs, physicians, institutional leaders, and advisors. Every affiliation verifiable. Below the testimonials: the transaction track record that makes the teaching credible, and the press that covered it.




Capturing Value at Exit: The $2.35 Billion Lesson from the Auris Health / Johnson & Johnson Acquisition.
The deepest testimonial AEIOU can offer is a case study of the deals that shaped the curriculum. The Auris / J&J transaction structured $2.35 billion of asymmetric value capture through mechanism design, not contract language. Part 1 walks through what happened. Part 2 shows the structural alternative that could have been written into the paper from day one.
Written by Christopher J. Velis, who founded Auris Health and served as its founding CEO and chairman. Johnson & Johnson acquired Auris for $5.75 billion in 2019.
Read the Structural Literacy Series →$10B+ in transactions structured. 30+ deals. 5+ countries.
Partial list. Additional closed transactions and financing rounds available on request.
Additional named testimonials and video interviews with AEIOU participants are in production and will publish on a rolling basis through spring and summer 2026.
The earlier you learn this, the less it costs.
A conversation about what your program, your board, or your company needs. No pitch deck. No commitment.
Schedule a consultation →


















